Cargando…
Risk Factors of Early Atrial Fibrillation Recurrence Following Electrical Cardioversion When Left Ventricular Ejection Fraction Is Preserved
Background and objectives: To identify clinical, echocardiographic, and laboratory parameters that affect the early recurrence of atrial fibrillation (AF) after restoring sinus rhythm (SR) by electrical cardioversion (ECV), and to determine whether left atrial (LA) strain, as a noninvasive indicator...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416115/ https://www.ncbi.nlm.nih.gov/pubmed/36013520 http://dx.doi.org/10.3390/medicina58081053 |
_version_ | 1784776400823123968 |
---|---|
author | Karaliūtė, Rasa Leleika, Arnoldas Apanavičiūtė, Ieva Kazakevičius, Tomas Mizarienė, Vaida Zabiela, Vytautas Kavoliūnienė, Aušra Ragaišytė, Nijolė Urbonienė, Daiva Šakalytė, Gintarė |
author_facet | Karaliūtė, Rasa Leleika, Arnoldas Apanavičiūtė, Ieva Kazakevičius, Tomas Mizarienė, Vaida Zabiela, Vytautas Kavoliūnienė, Aušra Ragaišytė, Nijolė Urbonienė, Daiva Šakalytė, Gintarė |
author_sort | Karaliūtė, Rasa |
collection | PubMed |
description | Background and objectives: To identify clinical, echocardiographic, and laboratory parameters that affect the early recurrence of atrial fibrillation (AF) after restoring sinus rhythm (SR) by electrical cardioversion (ECV), and to determine whether left atrial (LA) strain, as a noninvasive indicator reflecting fibrosis, is associated with laboratory indicators affecting the development of fibrosis, interleukin 6 (IL-6) or tumor necrosis factor α (TNF-α). Materials and Methods: The study included 92 persistent AF patients who underwent elective ECV. The effective maintenance of SR was evaluated after 40 ± 10 days of ECV. Echocardiography, inflammatory markers (high-sensitivity c-reactive protein (hs-CRP), IL-6, and TNF-α), and natriuretic peptides (N-terminal pro b-type natriuretic peptide (NT-proBNP) and N-terminal pro a-type natriuretic peptide (NT-proANP)) were assessed. Results: After a 40 ± 10 days observation period, 51 patients (55.4%) were in SR. Patients with AF recurrence had a significantly longer duration of AF (p = 0.008) and of arterial hypertension (p = 0.035), lower LA ejection fraction (p = 0.009), lower LA strain (p < 0.0001), higher left ventricular global longitudinal strain (p = 0.001), and a higher E/e‘ ratio (p < 0.0001). LA strain was an independent predictor of early AF recurrence (OR: 0.65; 95% Cl 0.5–0.9, p = 0.004). LA strain < 11.85% predicted AF recurrence with 70% sensitivity and 88% specificity (AUC 0.855, 95% CI 0.77–0.94, p < 0.0001). LA strain demonstrated the association with NT-proBNP (r = −0.489, p < 0.0001) and NT-proANP (r = −0.378, p = 0.002), as well as with hs-CRP (r = −0.243, p = 0.04). Conclusions: LA strain appeared to be the most accurate predictor of early AF recurrence after ECV in patients with persistent AF. LA strain inversely correlated with NT-proBNP and NT-proANP, but no significant association with any of the inflammatory markers was identified. |
format | Online Article Text |
id | pubmed-9416115 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94161152022-08-27 Risk Factors of Early Atrial Fibrillation Recurrence Following Electrical Cardioversion When Left Ventricular Ejection Fraction Is Preserved Karaliūtė, Rasa Leleika, Arnoldas Apanavičiūtė, Ieva Kazakevičius, Tomas Mizarienė, Vaida Zabiela, Vytautas Kavoliūnienė, Aušra Ragaišytė, Nijolė Urbonienė, Daiva Šakalytė, Gintarė Medicina (Kaunas) Article Background and objectives: To identify clinical, echocardiographic, and laboratory parameters that affect the early recurrence of atrial fibrillation (AF) after restoring sinus rhythm (SR) by electrical cardioversion (ECV), and to determine whether left atrial (LA) strain, as a noninvasive indicator reflecting fibrosis, is associated with laboratory indicators affecting the development of fibrosis, interleukin 6 (IL-6) or tumor necrosis factor α (TNF-α). Materials and Methods: The study included 92 persistent AF patients who underwent elective ECV. The effective maintenance of SR was evaluated after 40 ± 10 days of ECV. Echocardiography, inflammatory markers (high-sensitivity c-reactive protein (hs-CRP), IL-6, and TNF-α), and natriuretic peptides (N-terminal pro b-type natriuretic peptide (NT-proBNP) and N-terminal pro a-type natriuretic peptide (NT-proANP)) were assessed. Results: After a 40 ± 10 days observation period, 51 patients (55.4%) were in SR. Patients with AF recurrence had a significantly longer duration of AF (p = 0.008) and of arterial hypertension (p = 0.035), lower LA ejection fraction (p = 0.009), lower LA strain (p < 0.0001), higher left ventricular global longitudinal strain (p = 0.001), and a higher E/e‘ ratio (p < 0.0001). LA strain was an independent predictor of early AF recurrence (OR: 0.65; 95% Cl 0.5–0.9, p = 0.004). LA strain < 11.85% predicted AF recurrence with 70% sensitivity and 88% specificity (AUC 0.855, 95% CI 0.77–0.94, p < 0.0001). LA strain demonstrated the association with NT-proBNP (r = −0.489, p < 0.0001) and NT-proANP (r = −0.378, p = 0.002), as well as with hs-CRP (r = −0.243, p = 0.04). Conclusions: LA strain appeared to be the most accurate predictor of early AF recurrence after ECV in patients with persistent AF. LA strain inversely correlated with NT-proBNP and NT-proANP, but no significant association with any of the inflammatory markers was identified. MDPI 2022-08-04 /pmc/articles/PMC9416115/ /pubmed/36013520 http://dx.doi.org/10.3390/medicina58081053 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Karaliūtė, Rasa Leleika, Arnoldas Apanavičiūtė, Ieva Kazakevičius, Tomas Mizarienė, Vaida Zabiela, Vytautas Kavoliūnienė, Aušra Ragaišytė, Nijolė Urbonienė, Daiva Šakalytė, Gintarė Risk Factors of Early Atrial Fibrillation Recurrence Following Electrical Cardioversion When Left Ventricular Ejection Fraction Is Preserved |
title | Risk Factors of Early Atrial Fibrillation Recurrence Following Electrical Cardioversion When Left Ventricular Ejection Fraction Is Preserved |
title_full | Risk Factors of Early Atrial Fibrillation Recurrence Following Electrical Cardioversion When Left Ventricular Ejection Fraction Is Preserved |
title_fullStr | Risk Factors of Early Atrial Fibrillation Recurrence Following Electrical Cardioversion When Left Ventricular Ejection Fraction Is Preserved |
title_full_unstemmed | Risk Factors of Early Atrial Fibrillation Recurrence Following Electrical Cardioversion When Left Ventricular Ejection Fraction Is Preserved |
title_short | Risk Factors of Early Atrial Fibrillation Recurrence Following Electrical Cardioversion When Left Ventricular Ejection Fraction Is Preserved |
title_sort | risk factors of early atrial fibrillation recurrence following electrical cardioversion when left ventricular ejection fraction is preserved |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416115/ https://www.ncbi.nlm.nih.gov/pubmed/36013520 http://dx.doi.org/10.3390/medicina58081053 |
work_keys_str_mv | AT karaliuterasa riskfactorsofearlyatrialfibrillationrecurrencefollowingelectricalcardioversionwhenleftventricularejectionfractionispreserved AT leleikaarnoldas riskfactorsofearlyatrialfibrillationrecurrencefollowingelectricalcardioversionwhenleftventricularejectionfractionispreserved AT apanaviciuteieva riskfactorsofearlyatrialfibrillationrecurrencefollowingelectricalcardioversionwhenleftventricularejectionfractionispreserved AT kazakeviciustomas riskfactorsofearlyatrialfibrillationrecurrencefollowingelectricalcardioversionwhenleftventricularejectionfractionispreserved AT mizarienevaida riskfactorsofearlyatrialfibrillationrecurrencefollowingelectricalcardioversionwhenleftventricularejectionfractionispreserved AT zabielavytautas riskfactorsofearlyatrialfibrillationrecurrencefollowingelectricalcardioversionwhenleftventricularejectionfractionispreserved AT kavoliunieneausra riskfactorsofearlyatrialfibrillationrecurrencefollowingelectricalcardioversionwhenleftventricularejectionfractionispreserved AT ragaisytenijole riskfactorsofearlyatrialfibrillationrecurrencefollowingelectricalcardioversionwhenleftventricularejectionfractionispreserved AT urbonienedaiva riskfactorsofearlyatrialfibrillationrecurrencefollowingelectricalcardioversionwhenleftventricularejectionfractionispreserved AT sakalytegintare riskfactorsofearlyatrialfibrillationrecurrencefollowingelectricalcardioversionwhenleftventricularejectionfractionispreserved |